Blog

Cobra Biologics embarks on £15 million gene therapy manufacturing expansion – The Pharma Letter (registration)


Cobra Biologics embarks on £15 million gene therapy manufacturing expansion
The Pharma Letter (registration)
Cobra Biologics, an international contract development and manufacturing organization (CDMO) of biologics and pharmaceuticals, is to expand operations at its sites in the UK and Sweden to meet the increased demand of gene and immunotherapy ...

Flattr this!

2017-04-19 NEWS
About Michael Zand